Akari Therapeutics Plc (AKTX)

0.2111 -0.02 (-7.90%) USD  |  NASDAQ  |  Mar 16, 10:56
More

Akari Therapeutics EPS Diluted (Quarterly) : -0.1947 for Sept. 30, 2025

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
DBV Technologies SA -1.207
Cellectis SA 0.0058
Biodexa Pharmaceuticals Plc --
Mereo BioPharma Group Plc -0.0436
Evaxion AS 0.7227

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -6.36M
Total Expenses (Quarterly) 6.36M
Enterprise Value 10.07M
Earnings Yield -185.4%